Atlas Trials

Bioequivalence Study of Two Formulations of Propafenone 300 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting Conditions

Clinical trial NCT03915340 · COMPLETED

Trial details

NCT number
NCT03915340
Sponsor
Pharmtechnology LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Bioequivalence
Start date
2019-03-23
Primary completion
2019-05-08
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.